BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SVACS - ECPv6.15.1.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.siliconvalleyacs.org
X-WR-CALDESC:Events for SVACS
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260422T150000
DTEND;TZID=America/Los_Angeles:20260422T160000
DTSTAMP:20261007T222603
CREATED:20260411T231020Z
LAST-MODIFIED:20260411T231020Z
UID:22622-1776870000-1776873600@www.siliconvalleyacs.org
SUMMARY:Quantum Dots: From Biology to Quantum Science (30th Annual Stauffer Lectureship\, Day 2 of 2)
DESCRIPTION:Prof. Moungi Bawendi\, MIT\nSponsored by Stanford Department of Chemistry\nApril 22nd\, 3:00-4:00 pm\, In-person\, Free\, Stanford University\, Sapp Center Auditorium (STLC111)\, Learn more\n\nUnderstanding the chemical properties and the fundamental optoelectronic behavior of colloidal quantum dots is a prerequisite to their varied applications. This talk will focus on two very different paths: the use of quantum dots in biological imaging\, and their prospect as quantum emitters\, to illustrate the potential\, the challenges\, and the solutions that emerge when working with hybrid systems at the nanoscale. \nAbout the Speaker\nProfessor Moungi Bawendi\, the Lester Wolfe Professor of Chemistry at MIT\, received his A.B. in 1982 from Harvard University and his Ph.D. in 1988 from The University of Chicago. This was followed by two years of postdoctoral research at Bell Laboratories\, working with Louis Brus\, where he began his studies on nanomaterials. Bawendi joined the faculty at MIT in 1990\, becoming Associate Professor in 1995 and Professor in 1996. \nProfessor Bawendi was one of the initial developers of the field of colloidal quantum dots. Driven by an interest in light-matter interactions\, he has followed an interdisciplinary research program that has probed the science and technology of chemically synthesized nanostructures. His work has advanced both fundamental studies as well as applications. His laboratory has demonstrated applications of nanomaterials for light emission\, photodetection\, spectral sensing\, solar energy harvesting\, and bio-imaging. His group has pioneered novel optical tools for the spectroscopy of single nanostructures. \nProfessor Bawendi’s studies have included: (1) the development of methods for synthesizing\, characterizing\, processing\, and assembling quantum dots\, magnetic nanoparticles\, J-aggregates\, and thin films of semiconducting perovskites\, (2) the study of the fundamental optical and magnetic properties of nanostructures using a variety of spectroscopic methods\, including the development of photon correlation tools to study single nanoscopic emitters and emitters of quantum ligtht\, (3) incorporating quantum dots\, magnetic particles\, J-aggregates\, and thin film materials into optical and opto-electronic device structures\, and (4) developing optical tools and probes\, both fluorescent as well as magnetic\, including nanoparticles and other contrast agents\, for biomedical imaging. \nProfessor Bawendi is a fellow of the American Association for the Advancement of Science\, a fellow of the American Academy of Arts and Sciences\, a fellow of the National Academy of Inventors\, a member of the US National Academy of Sciences\, and a member of the National Academy of Engineering. \nProfessor Bawendi is a co-laureate of the 2023 Nobel Prize in Chemistry.
URL:https://www.siliconvalleyacs.org/event/quantum-dots-from-biology-to-quantum-science-30th-annual-stauffer-lectureship-day-2-of-2/
LOCATION:In-person
CATEGORIES:Lecture
ATTACH;FMTTYPE=image/webp:https://www.siliconvalleyacs.org/wp-content/uploads/2026/04/Moungi-Bawendi-MIT-e1775948832682.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260608T170000
DTEND;TZID=America/Los_Angeles:20260608T190000
DTSTAMP:20261007T222603
CREATED:20260514T185859Z
LAST-MODIFIED:20260602T191937Z
UID:22751-1780938000-1780945200@www.siliconvalleyacs.org
SUMMARY:Reprogramming How We Interface with the Human Body:                           High-Resolution 3D Printing Can Make the Unmakeable
DESCRIPTION:Prof. Joseph M. DeSimone\, Departments of Radiology and Chemical Engineering\, Stanford University\nThe seminar on Monday\, June 8\, starts at 6:00 PM Pacific time.\nAn in-person networking hour on the Stanford campus precedes the live presentation from 5:00 – 6:00 PM.\nRegistration required for campus location or for Zoom link.  Registration deadline: Sunday\, June 7\, 1:00 PM. \n\nAbstract\nThroughout my career\, I’ve been guided by the belief that transformative advances in medicine don’t arise solely from new molecules\, but equally from rethinking how those molecules are formulated and delivered to the body. This mindset has led to a series of unconventional dosage and delivery innovations—from biodegradable drug-eluting stents (BVS\, Inc.\, acquired by Guidant and now part of Abbott; co-founded with Bob Langer)\, to precisely engineered microparticles for inhalation (Liquidia Technologies; NASDAQ: LQDA)\, to iontophoretic platforms for localized chemotherapy (Focal Medical; IND approved by the FDA\, with patients treated beginning March 2026)—each opening new therapeutic frontiers. \nToday\, advances in high-resolution 3D printing are enabling a new chapter in this journey: the ability to engineer the skin as a programmable biological interface. Using microscale additive manufacturing\, we can create intradermal delivery systems that precisely control where and how therapeutics are introduced\, while simultaneously enabling access to rich biological information through interstitial fluid. \nThis bi-directional paradigm—delivering therapies while sampling biology—opens a fundamentally new approach to medicine. By targeting the skin and its underlying lymphatic network\, we can more effectively engage the immune system\, access early disease signals\, and move beyond traditional blood-based diagnostics toward continuous\, minimally invasive liquid biopsy. \nImportantly\, this is not simply a new device or formulation—it represents a scalable platform. Rather than building a traditional therapeutic pipeline molecule by molecule\, these technologies enable a delivery-centric model that can be applied broadly across vaccines\, biologics\, and diagnostics. \nIn this talk\, I will outline how focusing on new dosage delivery forms and new devices for liquid biopsies—now powered by high-resolution 3D printing—is redefining our interface with the human body\, transforming both how we treat disease and how we measure health. \nSpeaker Background\nJoseph M. DeSimone \nSanjiv Sam Gambhir Professor of Translational Medicine and Chemical Engineering \nDepartments of Radiology and Chemical Engineering \nDepartment of Chemistry (by Courtesy) \nDepartment of Materials Science & Engineering (by Courtesy) \nGraduate School of Business (by Courtesy) \nStanford University \nProf. DeSimone is widely known by the Bay Area polymer science community and the academic world\, and his background\, interests\, and accomplishments are extensive and wide-ranging\, and far too long to fit in this note. For further information\, please see Stanford links: \nStanford Profile: https://profiles.stanford.edu/joseph-desimone \nResearch Group Website: https://desimonegroup.stanford.edu
URL:https://www.siliconvalleyacs.org/event/reprogramming-how-we-interface-with-the-human-body-how-high-resolution-3d-printing-can-make-the-unmakeable/
LOCATION:Hybrid
CATEGORIES:Webinar,Lecture
ATTACH;FMTTYPE=application/pdf:https://www.siliconvalleyacs.org/wp-content/uploads/2026/05/DeSimone_8June26_JointGGPF-SVACS_FLYER.pdf
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260722T190000
DTEND;TZID=America/Los_Angeles:20260722T200000
DTSTAMP:20261007T222603
CREATED:20260703T183240Z
LAST-MODIFIED:20260703T183240Z
UID:22822-1784746800-1784750400@www.siliconvalleyacs.org
SUMMARY:Exploring Strange New Worlds: Rocky Exoplanet Atmospheres with the James Webb Space Telescope
DESCRIPTION:Sponsored by Kavli Institute for Particle Astrophysics and Cosmology (KIPAC)\, Stanford University\n7:00-8:00 pm\, Hybrid\, Free\, Registration required\n\nEvent Details:\n\n\n\n\n\nHow important is an atmosphere for rocky planets? Join us to learn what JWST has discovered about the habitability of other worlds!\n\nThis lecture will be offered in a hybrid format\, is open to all\, and is recommended for adults and students in 9th grade and above.\n\n\nTitle: Exploring Strange New Worlds: Rocky Exoplanet Atmospheres with the James Webb Space Telescope \nSpeaker: Prof. Laura Schaefer (Stanford/KIPAC) \nAbstract: Can we learn about the history and geology of a rocky planet like Earth by measuring its atmosphere? In just a few decades\, astronomers have gone from wondering whether planets exist around other stars to discovering thousands of them. Now the James Webb Space Telescope (JWST) is taking the next step: not just finding these worlds\, but beginning to study what they’re like—including whether they have atmospheres at all\, which are critical for planetary habitability. In this talk\, we’ll meet the small\, rocky exoplanets that are most like the inner planets of our own Solar System\, and see how JWST looks for the faint chemical fingerprints of gases around distant worlds. We’ll also tour what JWST has discovered so far\, what has surprised us\, and why some planets seem to lose their atmospheres while others manage to hold on. Along the way\, we’ll connect these observations to bigger questions about how planets evolve—and what it might take for a world to be truly Earth-like. \nThe livestream URL can be found at the bottom of the EventBrite registration confirmation email. \n\n\n\n\n\n\nVisit this website for more information
URL:https://www.siliconvalleyacs.org/event/exploring-strange-new-worlds-rocky-exoplanet-atmospheres-with-the-james-webb-space-telescope/
LOCATION:Hybrid
CATEGORIES:Lecture
ATTACH;FMTTYPE=image/jpeg:https://www.siliconvalleyacs.org/wp-content/uploads/2026/07/Rocky-exoplanet-atmospheres.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260928T150000
DTEND;TZID=America/Los_Angeles:20260928T160000
DTSTAMP:20261007T222603
CREATED:20260919T184821Z
LAST-MODIFIED:20260919T184821Z
UID:22988-1790607600-1790611200@www.siliconvalleyacs.org
SUMMARY:The TG2/LRP1 Pathway: A Remarkable Mechanism for Antigen Presentation and More
DESCRIPTION:Prof. Chaitan Khosla\, Stanford University\nSponsored by Stanford Department of Chemistry\n3:00-4:00 pm\, In-person\, Stanford University\, Sapp Center Auditorium (STLC 111)\, 376 Lomita Drive\, Learn more\n\nIn our search for an explanation to the spectacular efficiency of gluten antigen presentation to the T cells that cause celiac disease\, we discovered an unexpected phenomenon. With help from an endocytic receptor\, a post-translational protein modifying enzyme partitions its catalytic cycle by binding to its substrate on one side of the cell membrane and releasing its product on the other. Dubbed the TG2/LRP1 pathway\, my lecture will focus on the chemical mechanism of this phenomenon\, its role in the pathobiology of celiac disease\, and the exploitation of these insights to advance a novel experimental medicine for celiac disease therapy into clinical trials. I will conclude by describing corollary efforts in collaboration with Bianxiao Cui’s laboratory that leverage our insights into the TG2/LRP1 pathway to prototype a different experimental medicine for the treatment of deadly fibrotic diseases. \nAbout the Speaker\nChaitan Khosla is a professor in the departments of Chemistry and Chemical Engineering at Stanford University. His research interests lie at the chemistry-biology interface. Chaitan received his PhD in 1990 at Caltech. After completing postdoctoral studies at the John Innes Centre in the UK\, he joined Stanford University in 1992. Over the past 30+ years he has mentored ~150 doctoral and postdoctoral trainees\, a vast majority of whom have gone on to successful careers in academia\, government or the biopharma industry across the globe. The Khosla lab’s current research interests are diverse and collaborative; they range from understanding the mechanistic and evolutionary logic of polyketide biosynthesis on enzymatic assembly-lines to fundamental and translational investigations into the pathobiology of disorders with high morbidity such as celiac disease\, Alzheimer’s disease and organ fibrosis. Chaitan served as the founding director of Stanford’s ChEM-H Institute from 2012 to 2020 and presently serves as the founding director of its Innovative Medicines Accelerator. He is an elected member of the American Academy for Arts and Science\, the U.S. National Academy of Engineering\, and the U.S. National Academy of Sciences. Recent honors include the 2026 Abeles and Jencks Award from the American Chemical Society.
URL:https://www.siliconvalleyacs.org/event/the-tg2-lrp1-pathway-a-remarkable-mechanism-for-antigen-presentation-and-more/
LOCATION:In-person
CATEGORIES:Lecture
ATTACH;FMTTYPE=image/webp:https://www.siliconvalleyacs.org/wp-content/uploads/2026/09/chaitan_khosla_0.jpg-e1789855305321.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20261008T150000
DTEND;TZID=America/Los_Angeles:20261008T163000
DTSTAMP:20261007T222603
CREATED:20260919T214849Z
LAST-MODIFIED:20260919T214849Z
UID:23034-1791471600-1791477000@www.siliconvalleyacs.org
SUMMARY:Improving All Lives Through Science: The Case for Fundamental Research\, Public Policy\, and Advocacy
DESCRIPTION:Wayne Elfed Jones Jr.\, current Chair of the ACS Board of Directors & recently retired Professor of Chemistry & Materials Science\, Provost & Vice President for Academic Affairs\, University of New Hampshire\nSponsored by Stanford Department of Chemistry\n3:00 pm-4:20 pm\, In-person\, Stanford University\, Sapp Center for Science Teaching and Learning\, Sapp Lecture Hall (STL 114)\, 376 Lomita Dr\, Stanford\, Learn more\n\nCuriosity-driven\, fundamental research fuels breakthrough technologies and lifesaving therapeutics—with chemistry at the center of it all. Yet\, as scientists\, we face a critical challenge: public trust in science is at a historic low\, and the policy decisions shaping research funding and implementation are evolving rapidly. How do we as researchers bridge the gap between bench science and societal impact? \nJoin us for an engaging discussion on the interplay among fundamental research\, public policy\, and national advocacy. Drawing on the history and modern initiatives of the American Chemical Society (ACS)\, this talk highlights how scientific societies advocate for the research enterprise and how individual researchers can directly influence policy. You will gain insight into the changing landscape of science funding and regulation\, as well as concrete tools\, fellowships\, and advocacy networks designed to help scientists translate their passion for chemical research into real-world policy outcomes. \nAbout the Speaker \nWayne E. Jones Jr. has served as a chemistry faculty member and researcher for 35 years\, recently retiring from his position as Provost and Vice President for Academic Affairs at the University of New Hampshire. ​​He earned a B.S. from St. Michael’s College in 1987 and a Ph.D. in inorganic chemistry from the University of North Carolina at Chapel Hill in 1991. He has been a member of ACS since 1989.  \nHe currently serves as Chair of the ACS Board of Directors\, leading the Board in its responsibility as the Society’s legal representative and overseeing the administration of its property\, funds\, and affairs. As a Director-at-Large\, he helps provide fiduciary oversight\, strategic direction\, and governance on behalf of the Society and its members.  Learn more
URL:https://www.siliconvalleyacs.org/event/improving-all-lives-through-science-the-case-for-fundamental-research-public-policy-and-advocacy/
LOCATION:In-person
CATEGORIES:Lecture
ATTACH;FMTTYPE=image/webp:https://www.siliconvalleyacs.org/wp-content/uploads/2026/09/wayne-jones_0.jpeg-e1789855351180.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20261026T150000
DTEND;TZID=America/Los_Angeles:20261026T160000
DTSTAMP:20261007T222603
CREATED:20260919T222004Z
LAST-MODIFIED:20260919T222004Z
UID:23044-1793026800-1793030400@www.siliconvalleyacs.org
SUMMARY:Strategies and Methods for Chemical Synthesis Inspired by Complex Natural Products
DESCRIPTION:Prof. Richmond Sarpong\, University of California\, Berkeley\nSponsored by Stanford Department of Chemistry\n3:00-4:00 pm\, in-person\, Stanford University\, Sapp Center Auditorium (STLC 111)\, 376 Lomita Drive\, Learn more\n\nNatural products continue to inspire and serve as a basis of new medicines. They also provide intricate problems that expose limitations in the strategies and methods employed in chemical synthesis. Several strategies and methods that have been developed in our laboratory and applied to the syntheses of architecturally complex natural products will be discussed. In particular\, new ways to employ the cleavage of core bonds such as C–C and C–N bonds to achieve skeletal editing will be presented. \nAbout the Speaker\nRichmond Sarpong is the Maxine J. Elliott University Professor of Chemistry at the University of California Berkeley where he and his group specialize in synthetic organic chemistry. Richmond became interested in chemistry after seeing\, firsthand\, the effectiveness of the drug ivermectin in combating river blindness during his childhood in Ghana\, West Africa. Richmond described his influences and inspirations in a TEDxBerkeley talk in 2015 (Face of Disease in Sub-Saharan Africa – https://www.youtube.com/watch?v=nIsY87-zkXA). Richmond completed his undergraduate studies at Macalester College in St. Paul\, MN and his graduate work was carried out with Prof. Martin Semmelhack at Princeton. He conducted postdoctoral studies at Caltech with Prof. Brian Stoltz. At Berkeley (since 2004)\, Richmond’s laboratory focuses on strategies and methods (including skeletal editing) for the synthesis of biologically active complex organic molecules that could form the basis for new pharmaceuticals. \nHe enjoys teaching and was the recipient of the 2009\, 2024\, and 2025 UC Berkeley Department of Chemistry teaching awards\, the 2016 Noyce Prize for Excellence in Undergraduate Teaching in the Physical Sciences at Berkeley\, and the 2021 ACS-DOC Edward Leete Award for teaching and research. Richmond’s research group has published over 180 papers and he has received numerous awards in recognition of his research including an Alfred P. Sloan Foundation Fellowship\, Japan Society for the Promotion of Science Fellowship\, Camille Dreyfus Teacher-Scholar Award\, ACS Cope Scholar Award\, NSF Career Award\, the 2015 Royal Society of Chemistry Synthetic Organic Chemistry Award\, a 2017 Guggenheim Fellowship\, the ISHC Katritzky Award\, the Society of Synthetic Organic Chemistry Japan Mukaiyama Award for 2019\, the and the ACS Award for Creative Work in Synthetic Organic Chemistry for 2022. He is also an elected member of the American Academy of Arts and Sciences (2020) and the US National Academy of Science (2025).
URL:https://www.siliconvalleyacs.org/event/strategies-and-methods-for-chemical-synthesis-inspired-by-complex-natural-products/
LOCATION:In-person
CATEGORIES:Lecture
ATTACH;FMTTYPE=image/webp:https://www.siliconvalleyacs.org/wp-content/uploads/2026/09/richmond_sarpong_0.jpg-e1789856294757.webp
END:VEVENT
END:VCALENDAR